{"id":36396,"date":"2026-02-25T09:34:31","date_gmt":"2026-02-25T09:34:31","guid":{"rendered":"https:\/\/diyhaven858.wasmer.app\/index.php\/lake-street-adjusts-aquestive-therapeutics-inc-aqst-valuation-model-on-expected-approval-delay\/"},"modified":"2026-02-25T09:34:31","modified_gmt":"2026-02-25T09:34:31","slug":"lake-street-adjusts-aquestive-therapeutics-inc-aqst-valuation-model-on-expected-approval-delay","status":"publish","type":"post","link":"https:\/\/diyhaven858.wasmer.app\/index.php\/lake-street-adjusts-aquestive-therapeutics-inc-aqst-valuation-model-on-expected-approval-delay\/","title":{"rendered":"Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay"},"content":{"rendered":"


\n<\/p>\n

\n

Aquestive Therapeutics, Inc. (NASDAQ:AQST) is among the <\/span>7 Oversold Pharma Stocks to Buy Now<\/strong>.<\/span><\/p>\n

\n
\n
\"Lake<\/div>\n<\/div>
Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay <\/figcaption><\/figure>\n

Aquestive Therapeutics, Inc. (NASDAQ:AQST) is among the most oversold stocks<\/strong>.<\/p>\n

TheFly\u00a0reported\u00a0on February 3 that Lake Street Capital Markets reduced its price target on\u00a0AQST\u00a0to $6 from $8\u00a0and\u00a0maintained\u00a0a Buy rating.\u00a0This update followed the company’s announcement that it would resubmit its application in the third quarter after receiving a Complete Response Letter for\u00a0Anaphylm.\u00a0In order to\u00a0account for the expected delay in approval, the company revised its revenue forecasts and\u00a0modified\u00a0its valuation.<\/p>\n

Aquestive Therapeutics, Inc. (NASDAQ:AQST) also revealed on February 20 that it will present new clinical results for its investigational product, Anaphylm (dibutepinephrine) sublingual film, at the 2026 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting, which will take place in Philadelphia from February 27 to March 2. Additional evidence bolstering Anaphylm’s profile as a non-invasive substitute for injectable epinephrine in the treatment of severe allergic responses, including anaphylaxis, will be presented in the presentations.<\/p>\n

Aquestive Therapeutics, Inc. (NASDAQ:AQST) is a specialty pharmaceutical company developing and commercializing orally administered and film-based drug delivery therapies for neurological and other central nervous system disorders.<\/p>\n

While we acknowledge the potential of AQST as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you\u2019re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock<\/u><\/b>.<\/p>\n

READ NEXT:\u00a012 Unstoppable Dividend Stocks to Buy According to Analysts\u00a0<\/b><\/strong>and\u00a0Dividend Champions, Contenders and Challengers list: 15 Highest Yielding Stocks<\/b><\/strong>.<\/p>\n

Disclosure: None.<\/p>\n<\/p><\/div>\n


\n
<\/p>\n","protected":false},"excerpt":{"rendered":"

Aquestive Therapeutics, Inc. (NASDAQ:AQST) is among the 7 Oversold Pharma Stocks to Buy Now. Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay Aquestive Therapeutics, Inc. (NASDAQ:AQST) is among the most oversold stocks. TheFly\u00a0reported\u00a0on February 3 that Lake Street Capital Markets reduced its price target on\u00a0AQST\u00a0to $6 from $8\u00a0and\u00a0maintained\u00a0a Buy rating.\u00a0This […]<\/p>\n","protected":false},"author":1,"featured_media":36397,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_daextam_enable_autolinks":"","jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[10],"tags":[3978,527,3979],"class_list":["post-36396","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news","tag-aquestive-therapeutics","tag-inc","tag-oversold-stocks"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/diyhaven858.wasmer.app\/wp-content\/uploads\/2026\/02\/ed14eb8ca4c67aab8328f4b931d1d016.jpeg","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/posts\/36396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/comments?post=36396"}],"version-history":[{"count":0,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/posts\/36396\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/media\/36397"}],"wp:attachment":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/media?parent=36396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/categories?post=36396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/tags?post=36396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}